Viewing Study NCT02712320


Ignite Creation Date: 2025-12-25 @ 4:25 AM
Ignite Modification Date: 2026-05-27 @ 6:17 AM
Study NCT ID: NCT02712320
Status: COMPLETED
Last Update Posted: 2019-03-26
First Post: 2016-02-22
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Open-Label Safety Extension Study in Patients Who Have Previously Participated and Have Benefited From LMIS 50 mg
Sponsor: Foresee Pharmaceuticals Co., Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostatic Neoplasms View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Prostate Neoplasm Cancer Carcinoma View
None Safety Extension View